Onkológia 2/2007
IMAGING OF GASTROINTESTINAL STROMAL TUMOR WITH 8FDG (FLUORODEOXYGLUCOSIS) METHOD OF POSITRON EMISSION
Because the basal therapeutic agent Imatinib Mesilate in gastrointestinal stromal tumor (GIST) influences very quickly the transport and metabolism of glucose, positron emission tomography with 18F-fluorodeoxyglucoce (PET/18FDG) is an exellent monitoring tool for the therapy response of this. The condition for quantification of this response is a initial investigation in the beginning of the treatment.
Keywords: positron emission tomography, PET, 18FDG, 18F-fluorodexyglucose, GIST, gastrointestinal stromal tumor, Imatinib mesylate.
